Learn About Advances in Liver Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.

You’ll also learn about the following:

  • Causes of liver disease in the United States
  • Hepatitis C
  • The economics of treating hepatitis C
  • Transmission of hepatitis C

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Viewers About Acute Hepatitis

OSUWexnerbloglogo2014 CME Webcast Teaches Viewers About Acute Hepatitis. For his discovery of the virus we now know as hepatitis B and his discovery of a vaccine against it, Dr. Barry Blumberg was awarded the Nobel Prize. At the time of his death, the Scientific Director of the Fox Chase Cancer Center where Blumberg worked said of him: “I think it’s fair to say that Barry prevented more cancer deaths than any person who’s ever lived.” Hepatitis B is only one of a number of viruses as well as drugs and other conditions that can cause acute hepatitis. Here in the studio, with our moderator, to tell us about the different causes of acute hepatitis is hepatologist and Assistant Professor of Internal Medicine, Dr. Sean Kelly. And then to discuss the fundamentals of management of patients with acute liver failure, Associate Professor of Internal Medicine and the Director of the Section of Hepatology at the Ohio State University, Dr. James Hanje.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of acute hepatitis and characteristics of each type; and IDENTIFY the difference between abnormal liver function tests/acute hepatitis and Acute Liver Failure.

You’ll also learn about the following:

  • Common causes of acute hepatitis
  • New developments in the management of acute liver failure
  • Initial lab testing in patients with acute hepatitis
  • The role of radiographic imaging in evaluation of acute hepatitis
  • Use of the ammonia level in acute liver failure
  • When and how to assess intracranial hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.